Abstract
Warfarin use is complicated by an erratic dose response. Warfarin is metabolized by two distinct subfamilies of the cytochrome P450 (CYP) complex. We describe two siblings with extreme sensitivity to warfarin who share an unusual CYP genotype. These individuals illustrate both the importance of genetics in influencing the metabolism of warfarin as well as the potential utility of genetic testing as a guide to prescribing this medication.
Original language | English |
---|---|
Pages (from-to) | 144-146 |
Number of pages | 3 |
Journal | American Journal of Hematology |
Volume | 67 |
Issue number | 2 |
DOIs | |
State | Published - 2001 |
Externally published | Yes |
Keywords
- Cytochrome P450 complex
- Siblings
- Warfarin